Navigation Links
Scientists discover new role for miRNA in leukemia
Date:12/9/2007

COLUMBUS, Ohio Scientists here have found that mini-molecules called micro-RNA may play a critical role in the progression of chronic myeloid leukemia (CML) from its more treatable chronic phase to a life-threatening phase, called blast crisis.

Furthermore, they discovered an entirely new function for these molecules. The researchers show that microRNAs can sometimes directly control a proteins function not just whether or not the protein is made by the cell, as has been believed.

The study, using cells from CML patients in blast crisis, suggests that certain progenitor white blood cells are kept from maturing when levels of one microRNA, called miR-328, fall abnormally low. Immature white cells then build up in the blood and bone marrow, a telltale sign that the patient has entered the therapy-resistant blast-crisis phase.

The findings are being presented at the 2007 annual meeting of the American Society of Hematology (ASH), Dec. 8-11 in Atlanta.

If verified, our study suggests that altering microRNA levels might represent a potentially new therapeutic strategy for CML patients who do not benefit from effective targeted agents such as imatinib (Gleevec) and dasatinib (Sprycel), says principal investigator Danilo Perrotti, assistant professor of molecular virology, immunology and medical genetics and a researcher with the Ohio State University Comprehensive Cancer Center.

The findings also reveal a new function for microRNAs, which should further our understanding of their role in cancer development and progression, and in normal cells.

Researchers have known for some time that microRNAs bind to molecules called messenger RNA, which are part of the cells protein-making machinery, and in this way help regulate the types and amount of proteins made by cells.

But this study shows for the first time that the microRNA molecules sometimes bind directly with proteins themselves and affect their function.

In this case, a microRNA called miR-328 binds with a protein that, in blast phase CML, prevents immature blood cells from maturing. We believe that miR-328 acts as a decoy molecule that normally ties up the protein, which enables the white blood cells to mature as they should, Perrotti says.

During progression from chronic-phase to blast-crisis CML, however, the level of miR-328 falls, allowing the protein to be extremely active. This keeps the progenitor white blood cells from maturing, thus favoring blast-crisis conditions.

These findings are important because they help us understand the biology of blast-crisis CML, and they may help unravel novel pathways responsible for the initiation and progression of leukemia generally, Perrotti says.


'/>"/>

Contact: Darrell E. Ward
darrell.ward@osumc.edu
614-293-3737
Ohio State University
Source:Eurekalert

Related medicine news :

1. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
2. Scientists Probe Sepsis Deadly Secrets
3. Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
4. Scientists Develop Natural Protection for Stored Foods
5. Scientists detect presence of marburg virus in african fruit bats
6. Scientists Spot Brains Free Will Center
7. Scientists ID Likely Culprit in Popcorn Lung
8. Scientists explain how insulin secreting cells maintain their glucose sensitivity
9. Scripps Research scientists shed new light on how antibodies fight HIV
10. Scientists, physicians present latest findings in personalized cancer treatment and prevention
11. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... , ... January 21, 2017 , ... ... its new medical office in Petaluma, located at 167 Lynch Creek Way. The ... to SRO sports medicine and rehabilitation services and on-site x-ray services. ...
(Date:1/20/2017)... ... ... Overseer at The House of Yahweh has posted a new publication this week pleading to ... time like no other and society needs to understand the only way to help make ... to sound like an old bible beater because religion has a bad rap these days ...
(Date:1/20/2017)... , ... January 20, 2017 , ... ... products to enhance people’s everyday lives, recently attended the January ECRM Trade Show ... ATP Science is known for its large range of supplements that keep the ...
(Date:1/20/2017)... ... ... “Mary Magdalene: Grace is Greater than Sin”: a unique and memorable piece ... “Mary Magdalene: Grace is Greater than Sin” is the creation of published author, Brenda ... women who had little knowledge of the female characters portrayed in the Holy Bible. ...
(Date:1/20/2017)... ... 2017 , ... “Christmas in Suffolk”: a story of love, secrets, and ... in Lafayette, Indiana where she works in a daycare and looks for inspiration in ... by Christian Faith Publishing, Sara Seymour’s new book is an adventure of love and ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)... , Jan 20, 2017 Research ... Hearing Aids Market (by Devices, Implant Types, OTC Amplifiers, Diagnostic ... report to their offering. ... Global Hearing Aids Market Sales Volume, Company ... the fast-evolving, high-growth hearing aid industry. The growing ...
(Date:1/20/2017)... 20, 2017  Palladian Health, a leading provider ... launch of an opioid management program which assists ... and helps stem the growing tide of dependence ... treat chronic non-cancer pain (back pain, neck pain, ... lack of evidence regarding long-term effectiveness. ...
(Date:1/19/2017)... -- Germany Cataract Surgery Devices Market ... "Germany Cataract Surgery Devices Market Outlook to 2022", provides ... market. The report provides value, in millions of US ... market segements - Phacoemulsification Equipment and Ophthalmic Viscoelastic Devices ... distribution shares data for each of these market segements, ...
Breaking Medicine Technology: